Simplex Trading
JBIO

Simplex Trading’s Jade Biosciences JBIO Stock Holding History

Simplex Trading’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.44K Sell
200
-200
-50% -$4.17K ﹤0.01% 8242
2026
Q1 		$5.62K Buy
400
+200
+100% +$2.9K ﹤0.01% 7808
2025
Q4 		$3.09K Buy
+200
New +$2.35K ﹤0.01% 7678
2025
Q1 		– Sell
-426
Closed -$39K – 8499
2024
Q4 		$39K Buy
426
+397
+1,369% +$34.2K ﹤0.01% 6105
2024
Q3 		$2K Sell
29
-268
-90% -$17.3K ﹤0.01% 7948
2024
Q2 		$17K Buy
+297
New +$197K ﹤0.01% 7022

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's JBIO Position: Q2 2026 in Review

Simplex Trading sold out of Jade Biosciences (JBIO) in Q2 2026, closing a stake of 83 shares — an estimated $1.73K sold.

Simplex Trading first reported a position in JBIO in Q2 2024 and held it in 6 quarters. The position peaked at $49K in Q4 2024. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Simplex Trading reported no remaining Jade Biosciences position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 83 Jade Biosciences shares in Q2 2026, an estimated $1.73K.
  • Simplex Trading first reported a position in Jade Biosciences in Q2 2024 and held it in 6 quarters.
  • Simplex Trading's Jade Biosciences position peaked at $49K in Q4 2024.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.